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The coincidence of left ventricular (LV) non-compaction (NC) and long QT syndrome (LQTS) is rarely described. We present 
the case of a 22-year-old woman transferred to the intensive care unit after ventricular fibrillation, which she experienced 
under stress while giving a lecture. Her 45-year-old mother had experienced sudden cardiac death (SCD). She was uncon-
scious (GCS6). Echocardiography revealed severe systolic dysfunction (LVEF 20%) with apical lateral and posterior segments 
non-compacted. The criteria of Jenni et al. (Heart, 2001; 86: 661–671) (non-compacted/compacted ratio at end-systole > 2) 
and Chin et al. (Circulation, 1990; 82: 507–513) (compacted/non-compacted+compacted end-diastolic ratio ≥ 0.33 with 
communication between the recesses and LV) were fulfilled. Electrocardiograms (ECG) confirmed prolonged QT interval (Fig. 1) 
— QT interval in lead II is 760 ms. The overt T-wave alternans is seen best in limb leads. The presence of QT interval disper-
sion above 80 ms confirms the LQTS diagnosis. The QT interval, in lead II, ends in a P-wave. In the course of intensive care, 
many ventricular tachycardias — torsade de pointes (TdP) were observed (Fig. 2) and treated (amiodarone, then lignocaine). 
On the 5th day brain death was observed. The autopsy revealed biventricular dilatation with mild endocardial fibrosis with 
persistent sinusoid vessels — pathomorphological synonym 
of NC. In the reported patient, one should suspect a con-
genital origin: the family history of SCD, acute onset, no 
history of disease or medication intake and another genetic 
disorder — LVNC. LQTS includes also the T shape changes: 
widening, reversing and notching and macroscopic T-wave 
alternans. In the presented ECG, on the one hand, T-wave 
is slowly generated with a wide base that may resemble the 
LQTS1 pattern; but on the other hand, T wave is inscribed 
after a very long ST segment as in LQTS3. A clinical history 
of stress is characteristic for LQTS1. A recently released 
document states that LQTS should be diagnosed in the 
presence of a QT interval corrected for heart rate using 
Bazett’s formula (QTc) ≥ 500 ms in repeated 12-lead ECG, 
and in the absence of a secondary cause for QT prolonga-
tion. TdP episodes start with a ‘short–long–short’ sequence 
of RR cycles including premature ventricular beat with short 
coupling (Fig. 2). The pathomechanism of QT prolongation is 
transmural myocardial repolarisation dispersion with action 
potential prolongation in the medial layer. The interlayer 
differentiation is also well recognised in LVNC. We may 
search for the pathogenesis of QT prolongation not solely 
in channelopathy, but also in the layer alterations in LVNC. 
Arrhythmic potential might have been increased by amio-
darone. In summary, the coincidence of LVNC with systolic 
dysfunction and LQTS with TdP is rarely described. In our 
case, it proved fatal, despite adequate therapy. 
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Figure 1. Sinus rhythm 62/min. Low voltages of R waves in all 
leads, QTc prolongation to 776 ms and T-wave alternans (ar-
rows in limb leads), QT dispersion (arrows in precordial leads) 
are observed
Figure 2. After second evolution ventricular tachycardia — tor-
sade de pointes is recorded. This is preceded by polymorphic 
ventricular premature beats (including a pair — fifth and sixth 
evolution, arrows)
